New FP7 eHealth Project - COMOESTAS

COMOESTAS aims to develop an innovative ICT system that allows patients with Medication Overuse Headache (MOH), a common condition and a major cause of disability, to receive continuous and personalised treatment. The system will be based on an advanced Alerting and Decision Support System that follows patients from the diagnosis and supports the physician in managing the therapy, controlling relevant events impacting on patient safety.

Medication Overuse Headache (MOH) results from the chronicisation of primary forms of headaches, as a consequence of the progressive increase in the intake of symptomatic drugs. The first choice treatment for MOH is the withdrawal of the overused medication(s) (detoxification), which is preferentially done by hospitalising the patients. Even if most patients improve as a result of detoxification, up to 45% of patients relapse, reverting to the overuse of symptomatic drugs.

Paper diaries and calendars for recording headache attacks have long been used in the clinical practice for the management of headache patients. Isolated attempts to electronically record headache attacks have also been performed, based on the use of single common files.

At present, however, there is no scientifically validated informative tool that could manage patient's treatment, from the first observation to the whole follow-up. The availability of such a tool would grant an innovative approach to MOH.

Objectives of the project and project description
The general objective of the COMOESTAS project is to improve and integrate the management of MOH with an innovative electronic tool that makes the patient himself a key node in the treatment process. The new system, will be based on a complex informative system called Interactive Electronic Patient Record (IEPR) and will constitute an "all-inone" solution that will allow constant monitoring of the clinical condition of the patient by the doctor and provide a system of alerts and warnings should selected parameters exceed given thresholds. The system will also be designed in order to improve the patientdoctor communication.

Expected Results and Impacts
The constant monitoring by means of the electronic diary and programmed or alertprompted follow-up visits permit and favour a better interaction between patient and physician in order to ameliorate the management of these patients after the withdrawal. Furthermore, this will increase patient safety by optimising medical interventions, preventing errors and reducing drug-induced side effects (i.e. gastritis, hypertension). As a consequence, direct (consultations, hospitalisations, etc.) and indirect (i.e. linked to the disability and complications caused by the disease) costs provoked by the condition will be reduced.

Work in progress

  • The kick-off meeting took place in Pavia, on February 14-16
  • Indicators, clinical protocol and clinical tools have been devised, and will be finalised in April
  • The beta version of the IEPR system will be ready for pilot testing by the end of May
  • Clinical centres in Argentina and Chile are collecting data on the epidemiological impact of MOH in Latin America

For further information, please visit:
http://www.comoestas-project.eu

Related article:

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...